Literature DB >> 64747

Bone-marrow transplant from an unrelated donor for chronic granulomatous disease.

.   

Abstract

A boy with chronic granulomatous disease received a bone-marrow graft from a fully compatible unrelated donor, in association with a modified immunosuppressant regimen. He showed considerable clinical improvement with definite evidence of engraftment, and he has enjoyed a normal life for over 3 years.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 64747

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  5 in total

1.  Who pioneered the use of alternative donors (and stem cells from peripheral blood) in bone marrow transplantation?

Authors:  K Hughes-Jones; S Selwyn; P G Riches
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

Review 2.  Host defenses against infection: importance of phagocytic mechanisms from the study of genetic disorders of leukocyte function.

Authors:  R K Root
Journal:  Bull N Y Acad Med       Date:  1982-11

3.  Long-term follow-up and prognosis of chronic granulomatous disease in Yugoslavia: is there a role for early bone marrow transplantation?

Authors:  Srdjan Pasic; Aleksandra Minic; Predrag Minic; Dobrila Veljkovic; Desa Lilic; Bojana Slavkovic; Nada Pejnovic; Mario Abinun
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

4.  Bone marrow aplasia following donor lymphocyte infusion in 4-year-old patient with chronic granulomatous disease after allogeneic stem cell transplantation: case report.

Authors:  Magdalena Cienkusz; Monika Lejman; Nel DĄbrowska-Leonik; Marta Choma; Katarzyna Drabko
Journal:  Cent Eur J Immunol       Date:  2020-09-24       Impact factor: 2.085

5.  Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease.

Authors:  C Schuetz; M Hoenig; S Gatz; F Speth; U Benninghoff; A Schulz; K M Debatin; W Friedrich
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.